You are here
Home 🌿 Marijuana Politics 🌿 How Can Canadian Licensed Producers Capitalize On The Worlds #1 Importer Of Medical Cannabis? 🌿How Can Canadian Licensed Producers Capitalize On The Worlds #1 Importer Of Medical Cannabis?
During the last year, we have noticed increased interest in the Israeli cannabis market and this is a market that we have been favorable on since inception. The climate in Israel is ideal for cultivating cannabis and we are bullish on the industry due to the economics that are associated with it.
Earlier this month, we saw a spike in interest in companies that are levered to the Israeli cannabis market after HEXO Corp. (HEXO.TO) (HEXO) announced a supply agreement with Breath of Life (BOL), a leading Israeli cannabis company. The spike in interest also comes after Marijuana Business Daily reported that Israel surpassed Germany as the largest importer of medical cannabis flower in the world so far this year.
As a result of the increased interest in the Israeli cannabis market, we received a number of questions about Aurora Cannabis (ACB.TO) (ACB) as it relates to how the business is positioned to capitalize on the increasing demand for cannabis in international markets.
Aurora Cannabis was an early mover on the international cannabis market and is highly levered to the European Union (EU). Through a series of investments and acquisitions, the company has made itself a formidable player in the EU and this is an important aspect of the story. As it relates to the Canadian cannabis opportunity, the market has grown at a slower rate than expected and this has put additional pressure on Aurora Cannabis.
Going forward, the market is highly focused on how Aurora Cannabis is able to benefit from the increasing demand for medical cannabis in the EU. Based on the previous transactions completed by Aurora Cannabis, we would be surprised if it did not acquire an Israeli cannabis asset and this is an opportunity that we will continue to follow.
2020 has been a challenging year for Aurora Cannabis and we will monitor how the business is able to fare in the back half of the year. The name of the game for the company is execution and that is what the market is looking for. Aurora Cannabis needs to show that it can execute on previously announced initiatives as it does not have nearly as much cash on the balance sheet as it did in prior years.
Read entire article at Technical420.com
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.